ETS1 |
A549 (lung carcinoma) |
1 h with 0.02% Ethanol (Myers) |
Permissive
|
Homo sapiens |
ENCSR000BPU
|
MA0098.3
|
ETS1 |
CUTLL1 (T-cell lymphoblastic lymphoma 1) |
vehicle |
Permissive
|
Homo sapiens |
GSE51800
...
|
MA0098.3
|
ETS1 |
pre-B-cell progenitors |
IKDN CD2 Cre |
Permissive
Robust
|
Mus musculus |
GSE86897
...
|
MA0098.3
|
ETS1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
VEGF stimulation for 1hour |
Permissive
Robust
|
Homo sapiens |
GSE93030
...
|
MA0098.3
|
ETS1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
VEGF stimulation for 4hours |
Permissive
Robust
|
Homo sapiens |
GSE93030
...
|
MA0098.3
|
ETS1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
VEGF stimulation for 12hours |
Permissive
Robust
|
Homo sapiens |
GSE93030
...
|
MA0098.3
|
ETS1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 0 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0098.3
|
ETS1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 1 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0098.3
|
ETS1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 4 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0098.3
|
ETS1 |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BKA
|
MA0098.3
|
ETS1 |
K562 (myelogenous leukemia) |
|
Permissive
|
Homo sapiens |
ENCSR000BKQ
|
MA0098.3
|
ETS1 |
GM23338 |
|
Permissive
Robust
|
Homo sapiens |
ENCSR534VHI
|
MA0098.3
|
ETS1 |
HepG2 (hepatoblastoma) |
|
Permissive
|
Homo sapiens |
ENCSR681WHQ
|
MA0098.3
|
ETS1 |
T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE29362
...
|
MA0098.3
|
ETS1 |
Jurkat E6.1 (T-cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE17954
...
|
MA0098.3
|
ETS1 |
Th2-cells |
|
Permissive
Robust
|
Mus musculus |
GSE20898
...
|
MA0098.3
|
ETS1 |
CH12.LX (Mouse lymphoma) |
|
Permissive
Robust
|
Mus musculus |
ENCSR000ERA
...
|
MA0098.3
|
ETS1 |
MEL cell line |
|
Permissive
Robust
|
Mus musculus |
ENCSR000ETB
...
|
MA0098.3
|
ETS1 |
G1ME (megakaryocyte progenitor cell line) |
|
Permissive
|
Mus musculus |
GSE31331
...
|
MA0098.3
|
ETS1 |
CD4+ T-cells |
|
Permissive
|
Mus musculus |
GSE40684
...
|
MA0098.3
|
ETS1 |
CD4+ T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE40684
...
|
MA0098.3
|
ETS1 |
CD4+ CD25+ CD45RA+ T-cells |
|
Permissive
Robust
|
Homo sapiens |
GSE43119
...
|
MA0098.3
|
ETS1 |
CD4+ CD25+ CD45RA+ T-cells |
|
Permissive
Robust
|
Homo sapiens |
GSE43119
...
|
MA0098.3
|
ETS1 |
CD4+ CD25+ CD45RA+ T-cells |
|
Permissive
Robust
|
Homo sapiens |
GSE43119
...
|
MA0098.3
|
ETS1 |
CD4+ CD25- T-cells |
|
Permissive
Robust
|
Homo sapiens |
GSE43119
...
|
MA0098.3
|
ETS1 |
CD4+ CD25- T-cells |
|
Permissive
Robust
|
Homo sapiens |
GSE43119
...
|
MA0098.3
|
ETS1 |
thymocytes |
|
Permissive
Robust
|
Mus musculus |
GSE56393
...
|
MA0098.3
|
ETS1 |
CD4+ T-cells |
|
Permissive
|
Mus musculus |
GSE67443
...
|
MA0098.3
|
ETS1 |
CD4+ T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE67443
...
|
MA0098.3
|
ETS1 |
P5424 (thymic cells) |
|
Permissive
Robust
|
Mus musculus |
GSE74042
...
|
MA0098.3
|
ETS1 |
pre-B-cell progenitors |
|
Permissive
Robust
|
Mus musculus |
GSE86897
...
|
MA0098.3
|
ETS1 |
primary splenic B-cells |
|
Permissive
Robust
|
Mus musculus |
GSE83758
...
|
MA0098.3
|
ETS1 |
RCC 7860 (Renal cell carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE86092
...
|
MA0098.3
|
ETS1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE93030
...
|
MA0098.3
|
ETS1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE93030
...
|
MA0098.3
|
ETS1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE93030
...
|
MA0098.3
|
ETS1 |
HEYA8 Ovarian cancer cell |
|
Permissive
|
Homo sapiens |
GSE101832
...
|
MA0098.3
|
ETS1 |
OVCAR8 (high grade ovarian serous adenocarcinoma) |
|
Permissive
|
Homo sapiens |
GSE101832
...
|
MA0098.3
|
ETS1 |
RWPE1 (prostate epithelial cells) |
|
Permissive
|
Homo sapiens |
GSE29808
|
MA0098.3
|
ETS1 |
DU145 (prostate carcinoma) |
|
Permissive
|
Homo sapiens |
GSE59021
|
MA0098.3
|
ETS1 |
PANC1 (pancreatic ductal adenocarcinoma) |
|
Permissive
|
Homo sapiens |
GSE59021
|
MA0098.3
|
ETS1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
VEGF_12H |
Permissive
Robust
|
Homo sapiens |
GSE41166
|
MA0098.3
|
ETS1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
VEGF_1H |
Permissive
Robust
|
Homo sapiens |
GSE41166
|
MA0098.3
|
ETS1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
VEGF_4H |
Permissive
Robust
|
Homo sapiens |
GSE41166
|
MA0098.3
|
ETS1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE41166
|
MA0098.3
|